Pfizer's Lipitor share slips, casting doubt on power of a loyalty program to save the brand

Matthew Arnold

January 25 2012

Seven weeks after Pfizer's main Lipitor patent expired in the US, the drug is down to 32% market share and ...

Your Name: *

Your Email Address: *

Recipient(s) Email Address: *

(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)

Subject:*

Your message:

Send Me A Copy

The e-mail address(es) that you supply to use this service will only be used to send the requested article.